Â¥
8.15
Dec 24
New Key Statistics Module, Z-Score and F-Score
SZSE:002365 Key Ratios
Market Cap ¥ M | 2,395.78 |
Enterprise Value ¥ M | 1,541.53 |
P/E(ttm) | 740.91 |
PE Ratio without NRI | 56.21 |
Forward PE Ratio | -- |
Price/Book | 1.20 |
Price/Sales | 3.08 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.69 |
Revenue (TTM) ¥ M | 788.00 |
EPS (TTM) ¥ | 0.01 |
Beneish M-Score | -2.31 |
10-y EBITDA Growth Rate % | 13.80 |
5-y EBITDA Growth Rate % | -8.70 |
y-y EBITDA Growth Rate % | -91.80 |
EV-to-EBIT | 390.06 |
EV-to-EBITDA | 390.06 |
PEG | -- |
Shares Outstanding M | 294.68 |
Net Margin (%) | 0.40 |
Operating Margin % | 1.09 |
Pre-tax Margin (%) | 0.44 |
Quick Ratio | 5.03 |
Current Ratio | 5.47 |
ROA % (ttm) | 0.13 |
ROE % (ttm) | 0.16 |
ROIC % (ttm) | -2.18 |
Dividend Yield % | 1.23 |
Altman Z-Score | 7.98 |
SZSE:002365 Number of Guru Trades
SZSE:002365 Volume of Guru Trades
Gurus Latest Trades with SZSE:002365
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002365 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Qianjiang Yongan Pharmaceutical Co Ltd Insider Transactions
No Available Data